Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by forhandlarenon Apr 28, 2023 12:33am
119 Views
Post# 35418497

RE:RE:13 going to hold?

RE:RE:13 going to hold?I'm sure that real competition will be lined up this time. 

But I don't follow the proposed logic in respect of the share price. These companies will not buy a slice of Sirona and thereby push the share price, instead - down the line - one if them could aquire the whole company in a buyout.

Until then, the best we can hope for is that new retail investors enter. So how do the company find new investors? 

The promised Q&A to start with and the audience based on social media marketing. After all the anti-aging is the holy grail not hard to get some buzz around.

Target a Hollywood celebrity that is turned down getting roles because of destroyed minic because of Botox etc. This is the treatment that should have been applied instead. Friends will follow to invest.

The anti-aging is what drives hope. Hope drives the share price. The management should help the world dream.

With a strong share price the buyout will not be cheap.

<< Previous
Bullboard Posts
Next >>